NCT05838417View on ClinicalTrials.gov

Promoting Informed Choice for Breast Cancer Screening: A Longitudinal Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

November 22, 2022

Primary Completion Date

April 28, 2025

Study Completion Date

April 1, 2026

Conditions
Breast Cancer
Interventions
BEHAVIORAL

REDS survey

R - Reactance, E - self-Exemption, D - Disbelief, S - Source derogation

Trial Locations (2)

19104

University of Pennsylvania, Philadelphia

80045

University of Colorado Hospital, Aurora

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Colorado, Denver

OTHER